/ / Moderna shares tank after FDA delays COVID vaccine for 12- to 17-year-olds

Moderna shares tank after FDA delays COVID vaccine for 12- to 17-year-olds


Moderna shares tank after FDA delays COVID vaccine for 12- to 17-year-olds



Shares in Moderna Inc. dropped at least 5% as trading opened Monday after a delay in the decision to approve the COVID-19 vaccine for adolescents ages 12-17.

Share on Google Plus

About Stupid Computer

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.
    Blogger Comment
    Facebook Comment

0 comments:

Post a Comment

Subscribe to: Post Comments ( Atom )